CORE--FLUORESCENCE ACTIVATED CELL SORTING (FACS)
CORE--FLUORESCENCE ACTIVATED CELL SORTING (FACS)
批准号:
6102720
负责人:
MICHAEL ANDREEFF
金额:
$16.32万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-06-07 至 2000-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The FACS Core facility provides cellular analysis to the
investigators of this program project. The laboratory has provided
and developed cutting edge techniques in single cell analysis.
With the focus of this grant on apoptosis, the TdT-b-dUTP assay
for apoptosis (TUNEL) was established and modified for
multiparameter analysis in combination with DNA and BUdR
measurements (cell cycle, ploidy), immunophenotype to analyze
progenitor cells and lineage restricted cell populations,
intracellular proteins related to apoptosis (bcl-2, p53, Rb), and
cell surface antigens including fas and MDR1. Recently, binding of
Annexin V to phosphatidyl serine (PS) was recognized as a test for
changes in the membrane lipid structure that precedes changes
detected by TUNEL in cells undergoing apoptosis. Quantitation of
cellular antigens is now available allowing us to determine the
Antibody Binding Capacity (ABC). Cell kinetic changes can be
studied in patients with infusion of IUdR and BUdR and subsequent
analysis by flow cytometry. Fluorescence in situ hybridization
(FISH) has also been combined with the apoptosis-assays, allowing
us to discriminate apoptosis in normal and leukemic cells. The
number, phenotype and proliferation of residual leukemic cells
(MRD) with abnormalities amenable to FISH analysis can be
determined at levels of as few as 1 leukemic in 30,000 normal
cells. This assay is predictive of remission duration and will be
applied to patients after induction therapy and bone marrow
transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML
-
批准号:10356325
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2022
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Therapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML
-
批准号:10550265
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2022
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
-
批准号:10663157
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2019
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
-
批准号:9806956
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2019
-
负责人:MICHAEL ANDREEFF
-
依托单位:
P53 Activation as Novel Therapeutic Strategy for Acute Myelogenous Leukemia
-
批准号:8499746
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2013
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia
-
批准号:7897533
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia
-
批准号:8056055
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Targeting Microenvironment / Leukemia Cell Interactions in CML
-
批准号:8000073
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Non-genotoxic p53 activation as novel therapeutic concept for lymphoma
-
批准号:7715218
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Plerixafor/G-CSF with Sorafenib for Acute Myelogenous Leukemia with FLT3-ITD Muta
-
批准号:7936811
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Plerixafor/G-CSF with Sorafenib for Acute Myelogenous Leukemia with FLT3-ITD Muta
-
批准号:8324135
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
P53 Activation as Novel Therapeutic Stratgey for Acute Myelogenous Leukemia
-
批准号:7468678
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Flow Cytometry
-
批准号:7695941
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Treatment of Metastatic Breast Cancer with Gene Modified Mesenchymal Stem Cells
-
批准号:7737051
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Fluorescence-Activated Cell Sorting (FACS) and Molecular Cytogenetics (FISH)
-
批准号:7270271
-
项目类别:
-
资助金额:$14.64万
-
财政年份:2007
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Targeting Regulators of Apoptosis in AML
-
批准号:7270264
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2007
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6649746
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6470779
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6796771
-
项目类别:
-
资助金额:$25.18万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY
-
批准号:6481853
-
项目类别:
-
资助金额:$25.41万
-
财政年份:2001
-
负责人:MICHAEL ANDREEFF
-
依托单位:
海外基金